CP
GILD icon

CenterBook Partners’s Gilead Sciences GILD Stock Holding History

CenterBook Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.14M Buy
+32,767
New +$4.32M 0.2% 123
2026
Q1 		– Sell
-6,940
Closed -$852K – 693
2025
Q4 		$852K Buy
+6,940
New +$843K 0.04% 399
2023
Q4 		– Sell
-9,495
Closed -$712K – 428
2023
Q3 		$712K Buy
+9,495
New +$730K 0.09% 288

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CenterBook Partners's GILD Position: Q2 2026 in Review

CenterBook Partners opened a new position in Gilead Sciences (GILD) in Q2 2026: 32,767 shares worth $4.14M. The stake represents 0.2% of the portfolio and ranks #123 among its holdings. This is a return to the name: CenterBook Partners previously reported a position in GILD as recently as Q4 2025.

CenterBook Partners first reported a position in GILD in Q3 2023 and has held it in 3 quarters since. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • CenterBook Partners held 32,767 shares of Gilead Sciences worth $4.14M as of Q2 2026.
  • Gilead Sciences was a new CenterBook Partners position in Q2 2026.
  • Gilead Sciences made up 0.2% of CenterBook Partners's portfolio in Q2 2026, its #123 holding.
  • CenterBook Partners first reported a position in Gilead Sciences in Q3 2023 and has held it in 3 quarters since.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.